Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$224.0M
+38.7% from 2023
Prescriptions
11K
$19,580.42 per claim
Patients
2,014
1,770 prescribers
Total spending, 2024
$224.1M
$111,182.00 per patient
Medicare prescription drug plans paid $224.0M for Zejula in 2024, for 11,438 prescriptions and refills to 2,014 patients (up 38.7% from 2023). The average cost per claim was $19,580.42.
California had the highest Medicare cost for Zejula in 2024: $34.7M for 1,670 claims, followed by New York ($18.8M).
John B Villeneuve, gynecological oncology in West Reading, PA, had the highest Medicare cost for Zejula in 2024: 96 claims costing $1.6M.
Zejula is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| John B Villeneuve West Reading, PA | Gynecological Oncology | 96 | 12 | $1.6M |
| Ali Zahir Willow Grove, PA | Nurse Practitioner | 80 | Under 11 | $1.3M |
| Ivor Benjamin |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,763 | 11,368 | 2,213 | $154.8M |
| 2023 | 1,596 | 10,016 | 1,884 | $161.4M |
| 2024 | 1,770 | 11,438 | 2,014 | $224.0M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Obstetrics & Gynecology |
| 64 |
| Under 11 |
| $1.1M |
| Chirag A Shah Seattle, WA | Gynecological Oncology | 52 | Under 11 | $1.1M |
| Lucybeth Nieves-Arriba Wilmington, NC | Gynecological Oncology | 58 | Under 11 | $1.0M |
| Erin A Salinas Portland, OR | Gynecological Oncology | 55 | Under 11 | $970K |
| Erica Bernhardt Greeley, CO | Hematology-Oncology | 31 | Under 11 | $921K |
| Suzanne M Volcko Syracuse, NY | Nurse Practitioner | 47 | Under 11 | $845K |
| Michael A Bookman Tucson, AZ | Medical Oncology | 45 | Under 11 | $838K |
| Eric Thomas Oklahoma City, OK | Gynecological Oncology | 42 | Under 11 | $759K |
| Alicia S Johnson Wilmington, NC | Nurse Practitioner | 41 | Under 11 | $742K |
| Mercedes K Rose San Francisco, CA | Nurse Practitioner | 33 | Under 11 | $740K |
| Reshma T Benny Augusta, GA | Physician Assistant | 34 | Under 11 | $713K |
| Triantafillos J Fillos Bayside, NY | Medical Oncology | 27 | Under 11 | $682K |
| Gina M Mantia-Smaldone Philadelphia, PA | Obstetrics & Gynecology | 37 | Under 11 | $678K |
| Shaylynn E Skorka Williamsville, NY | Physician Assistant | 25 | Under 11 | $677K |
| Christopher S Ho West Hills, CA | Hematology-Oncology | 12 | Under 11 | $677K |
| Muhammad M Alam Fresno, CA | Hematology-Oncology | 24 | Under 11 | $674K |
| Lai Hui Sacramento, CA | Hematology-Oncology | 39 | Under 11 | $656K |
| Nader Javadi Calabasas, CA | Hematology-Oncology | 14 | Under 11 | $642K |
| Donna M McNamara Hackensack, NJ | Hematology-Oncology | 33 | Under 11 | $617K |
| Peter G Rose Cleveland, OH | Gynecological Oncology | 34 | Under 11 | $617K |
| Laura L Holman Providence, RI | Gynecological Oncology | 35 | Under 11 | $616K |
| Kellie Rath Columbus, OH | Gynecological Oncology | 32 | Under 11 | $585K |
| Meekoo Dhar Staten Island, NY | Hematology-Oncology | 34 | Under 11 | $582K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Glaxosmithkline GSK | 11,448 | $224.1M |